Search - tctmd.com

Displaying 521 - 540 of 1071

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Opinion Off Script TCT 2017

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Kwan S. Lee

November 01, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Conference News PCR London Valves 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Shelley Wood

September 26, 2017

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Daily News

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

Caitlin E. Cox

September 19, 2017

News Daily News

Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib

Todd Neale

September 14, 2017

News Daily News

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

L.A. McKeown

September 07, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

Todd Neale

August 27, 2017

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Shelley Wood

August 27, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

L.A. McKeown

August 24, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

Advertisement

Live From Denver: TCT 2017, Day Four

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

NOAC Bleeding Risk Rises With Several Drug Combinations

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content